Health written question – answered on 5th March 2007.

Alert me about debates like this

Photo of Stephen O'Brien Stephen O'Brien Shadow Minister (Health)

To ask the Secretary of State for Health how many meetings officials have had with strategic health authority chief executives on the service level agreement applied to the provision of Recombinant Factor VIII to haemophiliacs; and whether the service level agreement has been finalised.

Photo of Caroline Flint Caroline Flint Minister of State (Department of Health) (Public Health)

On 12 February 2003 the Government announced an extra £88 million over three years to extend the availability of recombinant (synthetic) clotting factors for adult haemophiliacs in England. To help extend the availability of recombinant, the Government provided the following additional funding:

£ million
2003-04 13
2004-05 21.7
2005-06 53.4

This funding was made available following a long campaign by the haemophilia lobby groups. Funding was available from the programme budget.

The roll-out programme for recombinant began in January 2004, and all haemophilia patients in England are now eligible for treatment with recombinant products.

Funding is now allocated to strategic health authorities through the national health service bundle, and will be managed through a service level agreement.

Does this answer the above question?

Yes0 people think so

No1 person thinks not

Would you like to ask a question like this yourself? Use our Freedom of Information site.